Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lactobacillus acidophilus (enpac) in treatment of hepatic encephalopathy.

Literature DB >> 4957275

Lactobacillus acidophilus (enpac) in treatment of hepatic encephalopathy.

A E Read, C F McCarthy, K W Heaton, J Laidlaw.

Abstract

Entities: Disease Species

Mesh：

Substances：
Ammonia
Neomycin

Year: 1966 PMID： 4957275 PMCID： PMC1844589 DOI： 10.1136/bmj.1.5498.1267

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

× No keyword cloud information.

7 in total

1. TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

Authors: W A MACBETH; E H KASS; W V MCDERMOTT
Journal: Lancet Date: 1965-02-20 Impact factor: 79.321

2. TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

Authors: J C FENTON; E J KNIGHT; F W O'GRADY
Journal: Lancet Date: 1965-04-03 Impact factor: 79.321

3. Blood-ammonium levels in liver disease and hepatic coma.

Authors: E A PHEAR; S SHERLOCK; W H SUMMERSKILL
Journal: Lancet Date: 1955-04-23 Impact factor: 79.321

4. Systemic absorption of orally administered neomycin in liver disease.

Authors: P M LAST; S SHERLOCK
Journal: N Engl J Med Date: 1960-02-25 Impact factor: 91.245

5. A microdiffusion method for the determination of nitrogen liberated as ammonia.

Authors: D SELIGSON; H SELIGSON
Journal: J Lab Clin Med Date: 1951-08

6. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances.

Authors: G B PHILLIPS; R SCHWARTZ; G J GABUZDA; C S DAVIDSON
Journal: N Engl J Med Date: 1952-08-14 Impact factor: 91.245

Review 7. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration.

Authors: M Victor; R D Adams; M Cole
Journal: Medicine (Baltimore) Date: 1965-09 Impact factor: 1.889

7 in total

16 in total

Review 1. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.

Authors: T Gerber; H Schomerus
Journal: Drugs Date: 2000-12 Impact factor: 9.546

2. Genetics of antagonistic action and drug resistance inLactobacillus acidophilus.

Authors: S K Garg; B K Mital
Journal: World J Microbiol Biotechnol Date: 1992-03 Impact factor: 3.312

Review 3. Hepatic encephalopathy.

Authors: M S Losowsky; B B Scott
Journal: Br Med J Date: 1973-08-04

Lactobacillus acidophilus (enpac) in treatment of hepatic encephalopathy.

1. TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

2. TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

3. Blood-ammonium levels in liver disease and hepatic coma.

4. Systemic absorption of orally administered neomycin in liver disease.

5. A microdiffusion method for the determination of nitrogen liberated as ammonia.

6. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances.

Review 7. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration.

Review 1. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.

2. Genetics of antagonistic action and drug resistance inLactobacillus acidophilus.

Review 3. Hepatic encephalopathy.

4. The widening spectrum of neurological damage in liver disease.

5. The pathogenesis and medical treatment of hepatic encephalopathy.

6. Treatment of hepatic encephalopathy.

7. Alteration of fecal bacterial flora following oral administration of bifidobacterial preparation.

8. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.

9. Detection of Lactobacillus acidophilus in feces of humans, pigs, and chickens.

10. Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats.